**Author details**

Sara Lunardi1 \*, Francesca Lorenzoni<sup>2</sup> and Paolo Ghirri3

1 Paediatric and Neonatal Unit, S. Luca Hospital, Lucca, Italy

2 Division of Neonatology and Neonatal Intensive Care Unit, University Hospital of Pisa, Italy

3 Chief Division of Neonatology and Neonatal Intensive Care Unit, University Hospital of Pisa, Italy

\*Address all correspondence to: saralunardi@hotmail.it

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**65**

2007;**17**(4):253-276

*Universal Screening for Congenital CMV Infection DOI: http://dx.doi.org/10.5772/intechopen.89611*

[1] Fowler KB, McCollister FP, Sabo DL, Shoup AG, Owen KE, Woodruff JL, et al. A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics.

[8] Dar L, Pati SK, Patro AR, et al. Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. The Pediatric Infectious Disease Journal.

[9] Kaye S, Miles D, Antoine P, et al. Virological and immunological correlates of mother-to-child transmission of cytomegalovirus in the Gambia. The Journal of Infectious Diseases. 2008;**197**(9):1307-1314

[10] van der Sande MA, Kaye S, Miles DJ, et al. Risk factors for and clinical outcome of congenital cytomegalovirus infection in a periurban west-African birth cohort. PLoS

[11] Yamamoto AY, Mussi-Pinhata MM, Cristina P, Pinto G, Moraes Figueiredo LT, Jorge SM. Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate. The Pediatric Infectious Disease Journal.

2008;**27**(9):841-843

One. 2007;**2**(6):e492

2001;**20**(2):188-192

2009;**14**(9):19140

2011;**52**(2):e11-e13

[12] Ludwig A, Hengel H.

Epidemiological impact and disease burden of congenital cytomegalovirus infection in Europe. Eurosurveillance.

[13] Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary

versus non-primary maternal

[14] Marsico C, Kimberlin DW.

infection. Clinical Infectious Diseases.

Congenital cytomegalovirus infection: Advances and challenges in diagnosis, prevention and treatment. Italian Journal of Pediatrics. 2017;**43**:38

[15] James SH, Kimberlin DW. Advances in the prevention and treatment of

[3] Korver AM, Konings S, Dekker FW, et al. DECIBEL collaborative study group. Newborn hearing screening vs later hearing screening and developmental outcomes in

children with permanent childhood hearing impairment. Journal of the American Medical Association.

Lazzarotto T, et al. The "silent" global burden of congenital cytomegalovirus.

Pass RF. Maternal age and congenital cytomegalovirus infection: Screening of two diverse newborn populations, 1980-1990. The Journal of Infectious Diseases. 1993;**168**(3):552-556

[6] Dollard SC, Grosse SD, Ross DS. New

neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Reviews in Medical Virology. 2007;**17**(5):355-363

[7] Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in Medical Virology.

estimates of the prevalence of

**References**

2017;**139**(2):e20162128

2015;**372**(10):933-943

2010;**304**(15):1701-1708

2013;**26**(1):86-102

[5] Fowler KB, Stagno S,

[4] Manicklal S, Emery VC,

Clinical Microbiology Reviews.

[2] Kimberlin DW, Jester PM, Sánchez PJ, et al. National institute of allergy and infectious diseases collaborative antiviral study group. Valganciclovir for symptomatic congenital cytomegalovirus disease. The New England Journal of Medicine. *Universal Screening for Congenital CMV Infection DOI: http://dx.doi.org/10.5772/intechopen.89611*
